154 results
8-K
EX-99.1
CC
Chemours Company
30 Apr 24
The Chemours Company Reports First Quarter 2024 Results
4:32pm
, and Adjusted EBITDA, referred to throughout, principally exclude the impact of recent litigation settlements for legacy environmental matters … it is unable to predict with reasonable certainty the ultimate outcome of unusual gains and losses, potential future asset impairments and pending litigation
8-K
EX-99.1
CC
Chemours Company
28 Mar 24
Regulation FD Disclosure
8:18pm
quarter net loss on a GAAP basis was $18 million, or $0.12 per diluted share. Adjusting primarily for $62 million of after-tax litigation settlement … , or $0.12 per diluted share, adjusting primarily for $62 million of after-tax litigation settlement charges. Adjusted Net Income was $46 million
8-K
EX-99.1
CC
Chemours Company
27 Mar 24
The Chemours Company Reports Fourth Quarter and Full Year 2023 Results
6:09pm
diluted share
Adjusted Net Income1, which primarily excludes $62 million ($89 million pre-tax) in litigation settlement charges, was $46 million … in the corresponding prior-year quarter
Adjusted EBITDA1,2, which primarily excludes litigation settlement charges of $89 million, was $176 million
8-K
EX-99.1
dj02femeee
18 Mar 24
Chemours Receives NYSE Notice Regarding Delayed Form 10-K Filing
6:32pm
8-K
EX-99.1
ag6 g24ygp8
6 Mar 24
Chemours Provides update on Internal Review
9:28pm
NT 10-K
0ms3iboqrlj36 nrd
29 Feb 24
Notice of late annual filing
8:19am
8-K
EX-99.1
crze3pr
29 Feb 24
Results of Operations and Financial Condition
8:17am
8-K
EX-99.1
rrypyf7ouycbyk
13 Feb 24
Chemours Reschedules Earnings Release and Conference Call
4:19pm
CORRESP
y2go fhoj
22 Dec 23
Correspondence with SEC
12:00am
UPLOAD
ew4kz2w
13 Dec 23
Letter from SEC
12:00am
8-K
EX-99.1
kmu2073zxxin
26 Oct 23
The Chemours Company Announces Third Quarter 2023 Results
4:20pm
8-K
EX-10.1
khtfj 6jdwsprl5fd6b
23 Aug 23
Entry into a Material Definitive Agreement
5:23pm
8-K
EX-99.1
hx5e0tm1a
1 Aug 23
Chemours Completes Sale of Glycolic Acid Business to Iron Path Capital-backed PureTech Scientific, LLC for $137 Million
8:04am